These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8783473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subcutaneous sumatriptan in a clinical setting: the first 100 consecutive patients with acute migraine in a tertiary care center.
    Sheftell FD, Weeks RE, Rapoport AM, Siegel S, Baskin S, Arrowsmith F.
    Headache; 1994 Feb; 34(2):67-72. PubMed ID: 8163368
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE, Price WH, Dunbar A.
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
    [Abstract] [Full Text] [Related]

  • 4. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P, Ricalde O, Le Force B, Saper J, Margul B.
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP, Cady RK.
    Clin Ther; 2007 Feb; 29 Suppl():2511-9. PubMed ID: 18164918
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P, Vakaet A, Monseu G, Jacquy J, Bourgeois P, van der Linden C.
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of juvenile migraine with subcutaneous sumatriptan.
    MacDonald JT.
    Headache; 1994 Dec; 34(10):581-2. PubMed ID: 7843952
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group.
    Gross ML, Kay J, Turner AM, Hallett K, Cleal AL, Hassani H.
    Headache; 1994 Dec; 34(10):559-63. PubMed ID: 7843948
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
    Thomson AN, Arthur GP, Bergin PS, Pollock M, Parkin PJ, Flanagan M, Samson SA.
    N Z Med J; 1993 May 12; 106(955):171-3. PubMed ID: 8389026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.